Blistering Diseases in Newborns Dr

Total Page:16

File Type:pdf, Size:1020Kb

Blistering Diseases in Newborns Dr FAST FACTS FOR BOARD REVIEW Series Editor: William W. Huang, MD, MPH Blistering Diseases in Newborns Dr. Strowd is Assistant Professor of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. Lindsay C. Strowd, MD The author reports no conflict of interest. Diagnosis Clinical Findings Treatment Notes Infectious Diseases Herpes simplex virus Erythematous macules and Contact isolation, IV antivirals Highest risk of transmission is via (HSV) singular or grouped vesicles (eg, acyclovir), local wound care, active lesions in birth canal; 70% of primarily on the scalp and face; respiratory support, antiepileptics cases caused by HSV-2 infec- disseminated disease with for seizures, ophthalmic ointment tion; mortality rate of disseminated lethargy, fever, poor feeding, neonatal HSV infection >50% and hypotonia Pemphigus Superficial acral blisters and IV penicillin G (50,000 units/kg) Causative organism is Treponema syphiliticus erosions, condyloma lata, whitish every 12 h for 1 wk, pallidum; very rare manifestation plaques, organomegaly, bony wound care of congenital syphilis; acquired abnormalities transplacentally; requires repeat RPR test and CSF analysis until results are negative Staphylococcal Acute onset of erythema of the IV penicillin, clindamycin, Caused by exfoliative toxins of scalded skin face, trunk, and groin followed cephalosporin for MSSA, Staphylococcus aureus; infec- syndrome (SSSS) by superficial flaccid blisters vancomycin for MRSA tion typically stems from mucosal and exfoliation source (eg, oropharynx or nares), therefore lesional cultures are negative for S aureus Varicella Congenital varicella syndrome: Immediate treatment with Congenital varicella syndrome is scarring and/or vesicles in a VZIG, acyclovir (if VZIG is not a rare complication of maternal dermatomal pattern on the trunk, immediately available) exposure to varicella in first 20 wk hypoplasia of the arms and legs, of pregnancy; neonatal varicella microcephaly, ocular abnor- caused by neonatal exposure malities; neonatal varicella: dis- several days before or after delivery seminated vesicles with mucosal involvement Genetic Disorders Bullous congeni- Crops of superficial bullae and Local wound care for blisters, AD inherited defect in keratin 1/10; tal ichthyosiform erosions on the trunk, arms, or keratolytics once verrucous high risk of secondary infection in erythroderma legs with erythema at birth on the lesions present denuded skin trunk, arms, or legs; verrucous skin changes appear at 3 mo Dystrophic Tense blisters in sites of mild Aggressive wound care, minimize AD or AR inherited defect in epidermolysis bullosa trauma as well as widespread skin handling, hospital contact COL7A1, increased risk of SCC erosions, can also involve precautions to avoid infection, FEN in adulthood the gastrointestinal and gas- monitoring, temperature control trourinary tracts Epidermolysis Flaccid blisters and erosions Aggressive wound care, minimize AD inherited defect in bullosa simplex (EBS) in sites of mild trauma skin handling, hospital contact keratin 5/14 (eg, from placement of elec- precautions to avoid infection, FEN trodes or blood pressure cuff), monitoring, temperature control possible mucosal involvement continued on next page Copyright Cutis 2015. This page may be reproduced by dermatologists for noncommercial use. Cutis® Fast Facts for Board Review (continued) Diagnosis Clinical Findings Treatment Notes Junctional Tense blisters in sites of Aggressive wound care, minimize AR inherited defect in laminins epidermolysis mild trauma as well as on skin handling, contact precautions 5 (alpha 3, beta 3, gamma 2), bullosa (JEB) hands and feet to avoid infection, FEN monitoring, COL7A1, or integrin beta genes, temperature control which determines subtype; subtypes are determined by the specific defect but have similar clinical findings with the exception of JEB with pyloric atresia Kindler syndrome Congenital blistering on acral Local wound care, photoprotection, AR defect in KIND1, which contrib- skin and photosensitivity keratolytics for palmoplantar skin utes to cell adhesion; patients have (improves with age), pigmenta- increased risk of cutaneous SCC tion changes and skin atrophy in adulthood (worse with age); poikiloderma of the face and neck, palmo- plantar hyperkeratosis Ichthyosis bullosa of Skin fragility, blisters mostly on Initially local wound care and hospital AD inherited defect in keratin 2e; Siemens acral skin, diffuse erythema at contact precautions to limit second- tends to have islands of normal birth; blisters replaced by hyper- ary infection; keratolytics and emol- skin within areas of affected skin, keratotic plaques on the arms lients for hyperkeratotic skin somewhat unique to this ichthyosis and legs in early childhood subtype Incontinentia pigmenti Vesicles and blisters at birth Local wound care X-linked dominant defect in IKBKG following the lines of Blaschko; (also called NEMO) blisters evolve into verrucous lesions, then to hyperpigmented and hypopigmented macules later in life Transient bullous Large blisters on the arms Local wound care and prevention AR/AD defect in COL7A1; variant dermolysis of the and legs or areas of friction at of infection of epidermolysis bullosa newborn birth that can result in residual hypopigmentation and milia formation; usually resolves by 1 y of age Metabolic Disease Acrodermatitis Crusted papules, erosions, and Zinc replacement AR inherited defect in SLC39A4 enteropathica pus-filled vesicles around the responsible for zinc absorption; mouth and genitals, fussiness; earlier in formula-fed neonates due appears within weeks of birth to easier absorption of zinc from in bottle-fed neonates, upon human breast milk weaning in breastfed infants Miscellaneous Acral peeling skin Superficial desquamation of skin Minimize friction and heat on acral AR inherited mutation in TGM5; syndrome on the hands and feet, redness, skin, prevent secondary infection often misdiagnosed as EBS; flaccid blisters, itching with antibacterial soap, local exacerbated by heat, humidity, wound care and friction Aplasia cutis Most commonly appears on Local wound care, skin grafting for Idiopathic etiology; can result from congenita the scalp; localized absence of larger defects prenatal methimazole exposure the dermis, possible involvement of subcutaneous tissue and blister formation Copyright Cutis 2015. This page may be reproduced by dermatologists for noncommercial use. Cutis® Fast Facts for Board Review (continued) Diagnosis Clinical Findings Treatment Notes Bullous mastocytosis Diffuse eruption of tense, Wound care, glucocorticoids, Sporadic KIT mutation; can sometimes hemorrhagic blisters adrenaline, antihistamines, avoidance mimic SSSS that do not result in scarring; of triggers for mast cell degranulation can also present as an ery- thematous macular eruption; involvement of internal organs can cause GI bleeding and cardiovascular collapse Congenital Vesicles and superficial erosions Local wound care, infection prevention Increased risk of postnatal erosive and vesicular on the trunk and acral skin that HSV infection; affected neonates dermatosis heal with reticulated scarring; often are born prematurely alopecia, neurologic and oph- thalmologic complications Erythema toxicum Papules, vesicles, pustules, and Benign, self-limited condition; Incidence increases with neonatorum erythematous macules on the no treatment necessary gestational weight face, trunk, arms, and/or legs that appear within the first 72 h after birth Sucking blister 0.5–2 cm oval blisters on the Self-resolving Thought to be due to neonatal fingers, hands, and distal arms sucking on the affected body part in utero Transient neonatal Vesicles and pustules present Benign, self-limited condition; Most common in black patients pustular melanosis at birth on the arms, legs, trunk, no treatment necessary face, and/or buttocks; vesicles rupture easily resulting in hyper- pigmented macules that remain for several months Abbreviations: IV, intravenous; RPR, rapid plasma reagin; CSF, cerebrospinal fluid; MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; VZIG, varicella zoster immunoglobulin; AD, autosomal-dominant; AR, autosomal-recessive; FEN, fluid, electrolyte, and nutrition; COL7A1, collagen, type VII, alpha 1; SCC, squamous cell carcinoma; KIND1, kindlerin; IKBKG, NF-κB essential modulator; SLC39A4, solute carrier family 39 (zinc transporter), member 4; TGM5, transglutaminase 5; GI, gastrointestinal; KIT, mast cell growth factor receptor. Copyright Cutis 2015. This page may be reproduced by dermatologists for noncommercial use. Cutis® Fast Facts for Board Review Practice Questions 1. Which congenital blistering condition is caused by a mast cell growth factor receptor (KIT) mutation? a. aplasia cutis congenita b. bullous mastocytosis c. congenital erosive and vesicular dermatosis d. epidermolysis bullosa simplex e. ichthyosis bullosa of Siemens 2. What gene mutation is present in acrodermatitis enteropathica? a. collagen VII b. keratin 2e c. mast cell growth factor receptor d. NF-κB essential modulator e. solute carrier family 39 (zinc transporter), member 4 3. Which congenital blistering disease is associated with an increased risk of squamous cell carcinoma in adult patients? a. aplasia cutis congenita b. bullous mastocytosis c. Kindler syndrome d. pemphigus syphiliticus e. varicella 4. Which congenital blistering condition can be caused by prenatal exposure to methimazole? a. aplasia cutis congenita b. bullous mastocytosis c. dystrophic epidermolysis bullosa d. Kindler syndrome e. pemphigus syphiliticus 5. Which congenital blistering condition is caused by a mutation in transglutaminase 5? a. acral peeling skin syndrome b. aplasia cutis congenita c. bullous mastocytosis d. dystrophic epidermolysis bullosa e. Kindler syndrome Fact sheets and practice questions will be posted monthly. Answers are posted separately on www.cutis.com. Copyright Cutis 2015. This page may be reproduced by dermatologists for noncommercial use..
Recommended publications
  • Living with Mast Cell Activation Syndrome
    Anne Maitland, MD, PhD Living with Medical Director, Comprehensive Allergy Mast Cell & Asthma Care Activation Asst Professor, Dept of Medicine – Clinical Immunology Syndrome Icahn School of Medicine at Mt Sinai, New York Got MCAS? Mast Cell mediated disorders are common u 1 out of 2 of us are coping with some chronic immune mediated disorder. o ‘allergies’(rhinitis), sinus infections, hives (urticaria),food allergy/intolerance, skin swelling (angioedema), Anaphylaxis Signs and Symptoms eczema (atopic dermatitis and contact dermatitis), asthma issues, and the prototype of immediate hypersensitivity syndromes, anaphylaxis Why the rise in hypersensitivity disorders? Our genes in this environment! The human race has come to dominate its environment so completely that any analysis of the increase or appearance of a disease has to take changes in our lifestyle into account. In the case of allergic disease [hypersensitivity disorders] changes in our environment, diet, water quality, and personal behavior over the last 150 years have played a dominant role in the specificity of these diseases, as well as in prevalence and severity… it is clear that the consequences of hygiene, indoor entertainment, and changes in diet or physical activity have never been predicted. Thomas A. E. Platts-Mills, MD, PhD, FRS, The allergy epidemics: 1870-2010; J Allergy Clin Immunol 2015;136:3-13. Why? Trauma Stress Infection Connective Tissue Chemical Disorder exposure PIDD -manufactured Autoimmune Dz. -mold, Mastocytosis mycotoxins Hypertryptasemia (naturally Atopic Disorders occuring) Mast cell activation syndrome is easily treated, if it's But most patients with recognized MCAD suffer for Patients with mast cell activation syndrome (MCAS) frequently go for years without an accurate diagnosis… Harding, Reuters Health-New York, 2011 years… It is very common for one hypersensitivity condition to progress/morph into another, be provoked by more triggers.
    [Show full text]
  • The National Economic Burden of Rare Disease Study February 2021
    Acknowledgements This study was sponsored by the EveryLife Foundation for Rare Diseases and made possible through the collaborative efforts of the national rare disease community and key stakeholders. The EveryLife Foundation thanks all those who shared their expertise and insights to provide invaluable input to the study including: the Lewin Group, the EveryLife Community Congress membership, the Technical Advisory Group for this study, leadership from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), the Undiagnosed Diseases Network (UDN), the Little Hercules Foundation, the Rare Disease Legislative Advocates (RDLA) Advisory Committee, SmithSolve, and our study funders. Most especially, we thank the members of our rare disease patient and caregiver community who participated in this effort and have helped to transform their lived experience into quantifiable data. LEWIN GROUP PROJECT STAFF Grace Yang, MPA, MA, Vice President Inna Cintina, PhD, Senior Consultant Matt Zhou, BS, Research Consultant Daniel Emont, MPH, Research Consultant Janice Lin, BS, Consultant Samuel Kallman, BA, BS, Research Consultant EVERYLIFE FOUNDATION PROJECT STAFF Annie Kennedy, BS, Chief of Policy and Advocacy Julia Jenkins, BA, Executive Director Jamie Sullivan, MPH, Director of Policy TECHNICAL ADVISORY GROUP Annie Kennedy, BS, Chief of Policy & Advocacy, EveryLife Foundation for Rare Diseases Anne Pariser, MD, Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health Elisabeth M. Oehrlein, PhD, MS, Senior Director, Research and Programs, National Health Council Christina Hartman, Senior Director of Advocacy, The Assistance Fund Kathleen Stratton, National Academies of Science, Engineering and Medicine (NASEM) Steve Silvestri, Director, Government Affairs, Neurocrine Biosciences Inc.
    [Show full text]
  • Neonatal Dermatology Review
    NEONATAL Advanced Desert DERMATOLOGY Dermatology Jennifer Peterson Kevin Svancara Jonathan Bellew DISCLOSURES No relevant financial relationships to disclose Off-label use of acitretin in ichthyoses will be discussed PHYSIOLOGIC Vernix caseosa . Creamy biofilm . Present at birth . Opsonizing, antibacterial, antifungal, antiparasitic activity Cutis marmorata . Reticular, blanchable vascular mottling on extremities > trunk/face . Response to cold . Disappears on re-warming . Associations (if persistent) . Down syndrome . Trisomy 18 . Cornelia de Lange syndrome PHYSIOLOGIC Milia . Hard palate – Bohn’s nodules . Oral mucosa – Epstein pearls . Associations . Bazex-Dupre-Christol syndrome (XLD) . BCCs, follicular atrophoderma, hypohidrosis, hypotrichosis . Rombo syndrome . BCCs, vermiculate atrophoderma, trichoepitheliomas . Oro-facial-digital syndrome (type 1, XLD) . Basal cell nevus (Gorlin) syndrome . Brooke-Spiegler syndrome . Pachyonychia congenita type II (Jackson-Lawler) . Atrichia with papular lesions . Down syndrome . Secondary . Porphyria cutanea tarda . Epidermolysis bullosa TRANSIENT, NON-INFECTIOUS Transient neonatal pustular melanosis . Birth . Pustules hyperpigmented macules with collarette of scale . Resolve within 4 weeks . Neutrophils Erythema toxicum neonatorum . Full term . 24-48 hours . Erythematous macules, papules, pustules, wheals . Eosinophils Neonatal acne (neonatal cephalic pustulosis) . First 30 days . Malassezia globosa & sympoidalis overgrowth TRANSIENT, NON-INFECTIOUS Miliaria . First weeks . Eccrine
    [Show full text]
  • Revertant Mosaicism in a Human Skin Fragility Disorder Results from Slipped Mispairing and Mitotic Recombination
    Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination Dimitra Kiritsi, … , Leena Bruckner-Tuderman, Cristina Has J Clin Invest. 2012;122(5):1742-1746. https://doi.org/10.1172/JCI61976. Brief Report Dermatology Spontaneous gene repair, also called revertant mosaicism, has been documented in several genetic disorders involving organs that undergo self-regeneration, including the skin. Genetic reversion may occur through different mechanisms, and in a single individual, the mutation can be repaired in various ways. Here we describe a disseminated pattern of revertant mosaicism observed in 6 patients with Kindler syndrome (KS), a genodermatosis caused by loss of kindlin-1 (encoded by FERMT1) and clinically characterized by patchy skin pigmentation and atrophy. All patients presented duplication mutations (c.456dupA and c.676dupC) in FERMT1, and slipped mispairing in direct nucleotide repeats was identified as the reversion mechanism in all investigated revertant skin spots. The sequence around the mutations demonstrated high propensity to mutations, favoring both microinsertions and microdeletions. Additionally, in some revertant patches, mitotic recombination generated areas with homozygous normal keratinocytes. Restoration of kindlin-1 expression led to clinically and structurally normal skin. Since loss of kindlin-1 severely impairs keratinocyte proliferation, we predict that revertant cells have a selective advantage that allows their clonal expansion and, consequently, the improvement of the skin condition. Find the latest version: https://jci.me/61976/pdf Brief report Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination Dimitra Kiritsi,1 Yinghong He,1 Anna M.G. Pasmooij,2 Meltem Onder,3 Rudolf Happle,1 Marcel F.
    [Show full text]
  • Graft Versus Host Disease and How to Report It
    Graft versus Host Disease and how to report it Daniel Weisdorf MD University of Minnesota Transplant Events Day-8 0 1mo 3mo 6mo Conditioning HSCT Engraftment Mucositis Organ toxicity (VOD) Acute GVHD Chronic GVHD Infections Bacterial ----CMV---- Varicella----- --Fungus--------- Transplant Events Day-8 0 1mo 3mo 6mo Conditioning HSCT Engraftment Mucositis Organ toxicity (VOD) Acute GVHD Chronic GVHD Infections Bacterial ----CMV---- Varicella----- --Fungus--------- 1 Acute GVHD Chronic GVHD Skin: Lichen planus, Hyper/ hypo pigmentation, Dermatitis ichthyosis, onychodystrophy, morphea, + scleroderma, hair changes. Hepatitis Oral: sicca, atrophy, lichenoid, + Hyperkeratosis GI: wasting, dysphagia, Enteritis odynophagia, strictures Eye: keratoconjunctivitis sicca Lungs: Bronchiolitis obliterans Others: myofascial, genital Acute GVHD Chronic GVHD Dermatitis Rash + Hepatitis High bilirubin + Enteritis Nausea/vomiting/ diarrhea Acute GVHD Chronic GVHD Skin: Lichen planus, Scaly abnormal pigmentation, Dry skin, onychodystrophy, abnormal nails scleroderma, thick skin hair changes. Oral: sicca, atrophy, lichenoid, Dry mouth GI: wasting, dysphagia, Weight loss odynophagia, trouble swallowing Eye: keratoconjunctivitis sicca Dry eyes Lungs: Bronchiolitis obliterans Obstruction Others: myofascial, muscle stiffness Genital vaginal narrowing 2 Graft vs. Leukemia Effect • Less leukemia relapse follows more GVHD • Acute and particularly Chronic GVHD limit relapse Risk Factors for GVHD Acute GVHD Chronic GVHD Increased risk Increased risk HLA mismatch Older
    [Show full text]
  • COVID-19 and RARE SKIN DISEASES
    COVID-19 and RARE SKIN DISEASES Newsletter n°4, 8th June 2021 Dear all, We hope that this letter finds you well! Thank you to those who have included patients and collected the data! We would like to remind you to complete the online eCRF via the link you have received. If you any have any issues don’t hesitate to contact us. Please note that, since the pandemic is still continuing, the study has been expanded for one year. The monitoring is ongoing and the queries will be sent regularly. If needed, the sites will be contacted to discuss and validate the answers, and check if the study is proceeding well. 64 patients are included in the study: 5 in Germany, 6 in Czech Republic, 8 in Italy, 11 in Lithuania and 34 in France. The diseases concerned are the following: Bullous pemphigoid (9/64), Recessive dystrophic Epidermolysis bullosa (9/64), Dominant dystrophic Epidermolysis bullosa (8/64), Epidermolysis bullosa (7/64), Hidradenitis suppurativa (7/64), X-linked hypohidrotic ectodermal dysplasia (4/64), Lamellar ichtyosis (2/64) and Incontinentia pigmenti (2/64). The other diseases are presented each by 1 patient: Pemphigus vulgaris, Pemphigus foliaceous, Mucous membrane pemphigoid, IgA Linear Dermatosis, Dermatitis herpetiformis, Kindler Epidermolysis bullosa, Kerathinopathic ichthyosis, Darier disease, Linear morphea, Cloves syndrome, Microcystic lymphatic malformation, Hemihypertrophy (Overgrowth syndrome), Adamantiades - Behçet's disease, Hailey Hailey disease, Pityriasis rubra pilaris and Neurofibromatosis type 1 (Figure 1 below). 10 Figure 1: Type of Rare skin diseases 5 0 A large majority of patients visited a hospital physician (42%: 27/64), 28% visited a General practitioner (18/64) and 23% consulted a physician remotely (15/64).
    [Show full text]
  • RD-Action Matchmaker – Summary of Disease Expertise Recorded Under
    Summary of disease expertise recorded via RD-ACTION Matchmaker under each Thematic Grouping and EURORDIS Members’ Thematic Grouping Thematic Reported expertise of those completing the EURORDIS Member perspectives on Grouping matchmaker under each heading Grouping RD Thematically Rare Bone Achondroplasia/Hypochondroplasia Achondroplasia Amelia skeletal dysplasia’s including Achondroplasia/Growth hormone cleidocranial dysostosis, arthrogryposis deficiency/MPS/Turner Brachydactyly chondrodysplasia punctate Fibrous dysplasia of bone Collagenopathy and oncologic disease such as Fibrodysplasia ossificans progressive Li-Fraumeni syndrome Osteogenesis imperfecta Congenital hand and fore-foot conditions Sterno Costo Clavicular Hyperostosis Disorders of Sex Development Duchenne Muscular Dystrophy Ehlers –Danlos syndrome Fibrodysplasia Ossificans Progressiva Growth disorders Hypoparathyroidism Hypophosphatemic rickets & Nutritional Rickets Hypophosphatasia Jeune’s syndrome Limb reduction defects Madelung disease Metabolic Osteoporosis Multiple Hereditary Exostoses Osteogenesis imperfecta Osteoporosis Paediatric Osteoporosis Paget’s disease Phocomelia Pseudohypoparathyroidism Radial dysplasia Skeletal dysplasia Thanatophoric dwarfism Ulna dysplasia Rare Cancer and Adrenocortical tumours Acute monoblastic leukaemia Tumours Carcinoid tumours Brain tumour Craniopharyngioma Colon cancer, familial nonpolyposis Embryonal tumours of CNS Craniopharyngioma Ependymoma Desmoid disease Epithelial thymic tumours in
    [Show full text]
  • Emaciation, Congestive Heart Failure, and Systemic Amyloidosis In
    Case Report Emaciation, Congestive Heart Failure, and Systemic Amyloidosis in Severe Recessive Dystrophic Epidermolysis Bullosa: Possible Internal Complications Due to Skin-Derived Inflammatory Cytokines Derived from the Injured Skin Yoshiaki Matsushima y , Kento Mizutani y, Hiroyuki Goto y, Takehisa Nakanishi, Makoto Kondo, Koji Habe, Kenichi Isoda, Hitoshi Mizutani and Keiichi Yamanaka * Department of Dermatology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan; [email protected] (Y.M.); [email protected] (K.M.); [email protected] (H.G.); [email protected] (T.N.); [email protected] (M.K.); [email protected] (K.H.); [email protected] (K.I.); [email protected] (H.M.) * Correspondence: [email protected]; Tel.: +81-59-231-5025; Fax: +81-59-231-5206 These authors contributed equally to this work. y Received: 2 August 2020; Accepted: 7 September 2020; Published: 14 September 2020 Abstract: Inherited epidermolysis bullosa (EB) is a rare genetic skin disorder characterized by epithelial tissue fragility. Recessive dystrophic epidermolysis bullosa (RDEB) is the most severe form, characterized by the presence of blisters, erosion, and ulcer formation, leading to scarring and contraction of the limbs. RDEB is also associated with extra-cutaneous complications, including emaciation, congestive heart failure, and systemic amyloidosis. The main cause of these clinical complications is unknown; however, we hypothesized that they are caused by elevated circulating inflammatory cytokines overproduced by injured keratinocytes. We addressed this phenomenon using keratin-14 driven, caspase-1 overexpressing, transgenic (KCASP1Tg) mice in which injured keratinocytes release high levels of IL-1α and β.
    [Show full text]
  • Epidermolysis Bullosa (EB)
    OR Preparation for Patients with Epidermolysis Bullosa (EB) Background: Patients with EB have a mutation in their keratin or collagen genes. As a result the skin is not properly anchored and mere touch can cause the skin to slough or blister. Many different subtypes have been identified but the most common variant we see in our patient population is recessive dystrophic EB. The children appear as burn patients and are frequently wrapped in total body burn dressings. NO ADHESIVES MAY BE USED IN THESE PATIENTS. You will note the following in these children. Airway: the tissues of the lining of the mouth, tongue and esophagus are affected making eating difficult. Mouth opening is SEVERELY LIMITED and these patients are always considered difficult airways. FOI is the preferred method to intubate since we try to minimize contact with the mucosa. Digits: continued skin slough and scarring results in absence of fingernails and the fingers often fuse together. Cardiac: Over time, some children develop a cardiomyopathy. Anemia is common as is continued infections, so these children often appear to be in a high-output state. Renal: Many children develop renal failure over time. Hemotologic: Continued bleeding from wounds and poor nutrition causes anemia. Infections: These children are often colonized with MRSA in their wounds and many act as though in low-grade sepsis. You will see tachycardia and anesthetic resistance. IV access: Difficult though not as impossible as you would imagine. NO ELASTIC TOURNIQUETS! A hand tourniquet is sufficient. Alcohol wipes are not usually used. A small amount of baby shampoo on moistened gauze dabbed on and off with moist gauze may be used GI tract: Esophageal strictures are common due to sloughing and scarring of the esophagus, so patients coming in for these procedures often cannot handle their oral secretions and are drooling.
    [Show full text]
  • Hair Loss in Infancy
    SCIENCE CITATIONINDEXINDEXED MEDICUS INDEX BY (MEDLINE) EXPANDED (ISI) OFFICIAL JOURNAL OF THE SOCIETÀ ITALIANA DI DERMATOLOGIA MEDICA, CHIRURGICA, ESTETICA E DELLE MALATTIE SESSUALMENTE TRASMESSE (SIDeMaST) VOLUME 149 - No. 1 - FEBRUARY 2014 Anno: 2014 Lavoro: 4731-MD Mese: Febraury titolo breve: Hair loss in infancy Volume: 149 primo autore: MORENO-ROMERO No: 1 pagine: 55-78 Rivista: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA Cod Rivista: G ITAL DERMATOL VENEREOL G ITAL DERMATOL VENEREOL 2014;149:55-78 Hair loss in infancy J. A. MORENO-ROMERO 1, R. GRIMALT 2 Hair diseases represent a signifcant portion of cases seen 1Department of Dermatology by pediatric dermatologists although hair has always been Hospital General de Catalunya, Barcelona, Spain a secondary aspect in pediatricians and dermatologists 2Universitat de Barcelona training, on the erroneous basis that there is not much in- Universitat Internacional de Catalunya, Barcelona, Spain formation extractable from it. Dermatologists are in the enviable situation of being able to study many disorders with simple diagnostic techniques. The hair is easily ac- cessible to examination but, paradoxically, this approach is often disregarded by non-dermatologist. This paper has Embryology and normal hair development been written on the purpose of trying to serve in the diag- nostic process of daily practice, and trying to help, for ex- ample, to distinguish between certain acquired and some The full complement of hair follicles is present genetically determined hair diseases. We will focus on all at birth and no new hair follicles develop thereafter. the data that can be obtained from our patients’ hair and Each follicle is capable of producing three different try to help on using the messages given by hair for each types of hair: lanugo, vellus and terminal.
    [Show full text]
  • Ichthyosis: Case Report in a Colombian Man with Genetic Alterations in ABCA12 and HRNR Genes Ruben D
    Arias‑Pérez et al. BMC Med Genomics (2021) 14:140 https://doi.org/10.1186/s12920‑021‑00987‑y CASE REPORT Open Access Ichthyosis: case report in a Colombian man with genetic alterations in ABCA12 and HRNR genes Ruben D. Arias‑Pérez1, Salomón Gallego‑Quintero1, Natalia A. Taborda1 , Jorge E. Restrepo2, Renato Zambrano‑Cruz3 , William Tamayo‑Agudelo3, Patricia Bermúdez4, Constanza Duque4, Ismael Arroyave4, Johanna A. Tejada‑Moreno5, Andrés Villegas‑Lanau5, Alejandro Mejía‑García5, Wildeman Zapata6 , Juan C. Hernandez6* and Gina Cuartas‑Montoya3 Abstract Background: Ichthyosis is a heterogeneous group of diseases caused by genetic disorders related to skin formation. They are characterized by generalized dry skin, scaling, hyperkeratosis and frequently associated with erythroderma. Among its diferent types, harlequin ichthyosis (HI) stands out due to its severity. HI is caused by mutations in the ABCA12 gene, which encodes essential proteins in epidermal lipid transport, and it helps maintain the homeostasis of the stratum corneum of the epidermis. However, due to the wide spectrum of genetic alterations that can cause ichthyosis, holistic medical care, and genetic studies are required to improve the diagnosis and outcomes of these diseases. Case presentation: Here, we presented the case of a 19 years old male patient who was a premature infant and exhibited clinical features consistent with HI, including bright yellow hyperkeratotic plates with erythematous fssures that covered his entire body like a collodion baby. Currently, he exhibited erythroderma, photosensitivity, ectropion, auricular pavilion alterations, and musculoskeletal disorders, such as equinovarus feet, fngers, hands, and hypoplastic feet with contractures in fexion and marked difculty in fne motor skills.
    [Show full text]
  • Expression of Loricrin in Oral Submucous Fibrosis, Hyperkeratosis and Normal Mucosa: an Immunohistochemical Study
    EXPRESSION OF LORICRIN IN ORAL SUBMUCOUS FIBROSIS, HYPERKERATOSIS AND NORMAL MUCOSA: AN IMMUNOHISTOCHEMICAL STUDY Dissertation submitted to THE TAMILNADU Dr.M.G.R.MEDICAL UNIVERSITY In partial fulfillment for the Degree of MASTER OF DENTAL SURGERY BRANCH VI ORAL PATHOLOGY AND MICROBIOLOGY APRIL 2013 Acknowledgement It is not every day that we get to thank all those who really matter to us, and acknowledging this brings joy and pride so deep that it makes me feel whole and cherished .I would want to thank God foremost for his benevolence and love for making it possible, for every breath, every thought and every walk of life is filled with his goodness I would like to express my deep gratitude and reverence to my post graduate teacher and mentor Dr. K. Ranganathan, MDS, MS (Ohio), Ph.D, Professor and Head, Department of Oral and maxillofacial pathology, Ragas Dental College and Hospital for his valuable guidance, constant support and encouragement throughout my dissertation. His penchant for perfection in all things had been a beacon guiding us in our study. My sincere thanks to Dr. Umadevi K. Rao, Professor, Department of Oral and maxillofacial pathology Ragas Dental College and Hospital for her constant support, motivation to learn and encouragement in times of trials throughout my study. I extend my heartfelt gratitude to my Guide and Professor Dr. Elizabeth Joshua, Department of Oral and maxillofacial pathology Ragas Dental College and Hospital for her constant guidance, support, tons of patience and endearing words of advice to explore all aspects in the completion of my work. I earnestly thank Professor, Dr.
    [Show full text]